Loading…
Lobbying Spend
—
Filings
9
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 7383
Mikaela Naylon Give Kids a Chance Act
2026 · first_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1262
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: S. 1214
Give Kids a Chance Act of 2025
2026 · first_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: S. 932
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 7383
Mikaela Naylon Give Kids a Chance Act
2025 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1262
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: S. 1214
Give Kids a Chance Act of 2025
2025 · second_quarter · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $10,000
Matched citations: S. 932
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $40,000
Matched citations: H.R. 7383
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).
Client expense: — · Firm income: $40,000
Matched citations: S. 1214
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (H.R. 7383 / S. 1214, 118th Congress).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7383
Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (H.R. 7383 / S. 1214, 118th Congress).
Client expense: — · Firm income: $30,000
Matched citations: S. 1214
Source: Senate LDA